Three-dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic muscle

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 1, 2011, Pages 1-10

  Carnio, Silvia ^a,b   Serena, Elena ^a   Rossi, Carlo Alberto ^a,b,c   De Coppi, Paolo ^a,c   Elvassore, Nicola ^a,b   Vitiello, Libero ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biomaterials; Collagen scaffold; Dystrophin; Mdx; Muscle precursor cells; Reservoir

Indexed keywords

BIOMATERIALS; CELL DEATH; COLLAGEN; GENE THERAPY; SCAFFOLDS (BIOLOGY);

CELL INJECTION; COLLAGEN SCAFFOLDS; DUCHENNE MUSCULAR DYSTROPHIES; DYSTROPHIN; INTRAMUSCULAR; MDX; MUSCLE PRECURSOR CELLS; PRECURSOR CELLS; THREE-DIMENSIONAL POROUS SCAFFOLDS; WILD-TYPE CELLS;

MUSCLE;

BIOMATERIAL; COLLAGEN; DESMIN; DYSTROPHIN; MYOD PROTEIN; MYOGENIN; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; IN VITRO STUDY; IN VIVO STUDY; LONG TERM CARE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESERVOIR; STEM CELL TRANSPLANTATION; TIBIALIS ANTERIOR MUSCLE; WILD TYPE;

EID: 78650260899     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.282     Document Type: Article

References (34)

1. Bach AD, Beier JP, Stern-Staeter J, et al. 2004; Skeletal muscle tissue engineering. J Cell Mol Med 8: 413-422.
2. Beauchamp JR, Morgan JE, Pagel CN, et al. 1999; Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144: 1113-1121.
3. Bian WN, Bursac N. 2008; Tissue engineering of functional skeletal muscle: challenges and recent advances. IEEE Eng Med Biol Mag 27: 109-113.
4. Boldrin L, Elvassore N, Malerba A, et al. 2007; Satellite cells delivered by micro-patterned scaffolds: a new strategy for cell transplantation in muscle diseases. Tissue Eng 13: 253-262.
5. Callegari A, Bollini S, Iop L, et al. 2007; Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials 28: 5449-5461.
6. Cerletti M, Jurga S, Witczak CA, et al. 2008; Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134: 37-47.
7. Chin CD, Khanna K, Sia SK. 2008; A microfabricated porous collagen-based scaffold as prototype for skin substitutes. Biomed Microdevice 10: 459-467.
8. Ciardelli G, Gentile P, Chiono V, et al. 2010; Enzymatically crosslinked porous composite matrices for bone tissue regeneration. J Biomed Mater Res A 92(1): 137-151.
9. Cimetta E, Flaibani M, Mella M, et al. 2007; Enhancement of viability of muscle precursor cells on 3D scaffold in a perfusion bioreactor. Int J Artif Organs 30: 415-428.
10. De Coppi P, Bellini S, Conconi MT, et al. 2006; Myoblast-acellular skeletal muscle matrix constructs guarantee a long-term repair of experimental full-thickness abdominal wall defects. Tissue Eng 12: 1929-1936.
11. Fan Y, Maley M, Beilharz M, et al. 1996; Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19: 853-860.
12. Grounds MD. 2008; Two-tiered hypotheses for Duchenne muscular dystrophy. Cell Mol Life Sci 65: 1621-1625.
13. Gussoni E, Blau HM, Kunkel LM. 1997; The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3: 970-977.
14. Gussoni E, Pavlath GK, Lanctot AM, et al. 1992; Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356: 435-438.
15. Hill E, Boontheekul T, Mooney DJ. 2006; Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng 12: 1295-1304.
16. Huard J, Bouchard JP, Roy R, et al. 1991; Myoblast transplantation produced dystrophin-positive muscle fibres in a 16 year-old patient with Duchenne muscular dystrophy. Clin Sci (Lond) 81: 287-288.
17. Huard J, Bouchard JP, Roy R, et al. 1992; Human myoblast transplantation: preliminary results of four cases. Muscle Nerve 15: 550-560.
18. Huard J, Roy R, Guerette B, et al. 1994; Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve 17: 224-234.
19. Kinali M, Arechavala-Gomeza V, Feng L, et al. 2009; Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 8: 918-928.
20. Kinoshita I, Vilquin JT, Guerette B, et al. 1994; Very efficient myoblast allo-transplantation in mice under FK506 immunosuppression. Muscle Nerve 17: 1407-1415.
21. Kroehne V, Heschel I, Schugner F, et al. 2008; Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med 12: 1640-1648.
22. Montarras D, Morgan J, Collins C, et al. 2005; Direct isolation of satellite cells for skeletal muscle regeneration. Science 309: 2064-2067.
23. Muntoni F, Wells D. 2007; Genetic treatments in muscular dystrophies. Curr Opin Neurol 20: 590-594.
24. Partridge TA, Morgan JE, Coulton GR, et al. 1989; Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337: 176-179.
25. Peault B, Rudnicki M, Torrente Y, et al. 2007; Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Therapy 15: 867-877.
26. Price FD, Kuroda K, Rudnicki MA. 2007; Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta Mol Basis Dis 1772: 272-283.
27. Riboldi SA, Sampaolesi M, Neuenschwander P, et al. 2005; Electrospun degradable polyesterurethane membranes: potential scaffolds for skeletal muscle tissue engineering. Biomaterials 26: 4606-4615.
28. Sacco A, Doyonnas R, Kraft P, et al. 2008; Self-renewal and expansion of single transplanted muscle stem cells. Nature 456: 502-506.
29. Serena E, Flaibani M, Carnio S, et al. 2008; Electrophysiologic stimulation improves myogenic potential of muscle precursor cells grown in a 3D collagen scaffold. Neurol Disord 30: 207-214.
30. Skuk D, Caron NJ, Goulet M, et al. 2003; Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol 62: 951-967.
31. Skuk D, Goulet M, Roy B, et al. 2006; Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 65: 371-386.
32. Skuk D, Roy B, Goulet M, et al. 2004; Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Therapy 9: 475-482.
33. Tremblay JP, Skuk D. 2008; Another new 'super muscle stem cell' leaves unaddressed the real problems of cell therapy for Duchenne muscular dystrophy. Mol Therapy 16: 1907-1909.
34. Zhang SG, Gelain F, Zhao XJ. 2005; Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol 15: 413-420.